UK AMD/DR EMR REPORT IX: comparative effectiveness of predominantly as needed (PRN) ranibizumab versus continuous aflibercept in UK clinical practice

AIMS: To compare the effectiveness of continuous aflibercept versus pro re nata (PRN) ranibizumab therapy for neovascular age-related macular degeneration (nAMD). METHODS: Multicentre, national electronic medical record (EMR) study on treatment naive nAMD eyes undergoing PRN ranibizumab or continuou...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Ophthalmol
Main Authors: Lee, Aaron Y, Lee, Cecilia S, Egan, Catherine A, Bailey, Clare, Johnston, Robert L, Natha, Salim, Hamilton, Robin, Khan, Rehna, Al-Husainy, Sahar, Brand, Christopher, Akerele, Toks, Mckibbin, Martin, Downey, Louise, Tufail, Adnan
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5673590/
https://ncbi.nlm.nih.gov/pubmed/28478396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2016-309818
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados